REMSIMA Trademark

Trademark Overview

On Wednesday, July 27, 2011, a trademark application was filed for REMSIMA with the United States Patent and Trademark Office. The USPTO has given the REMSIMA trademark a serial number of 79103135. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Friday, November 13, 2015. This trademark is owned by CELLTRION, INC.. The REMSIMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders
remsima

General Information

Serial Number79103135
Word MarkREMSIMA
Filing DateWednesday, July 27, 2011
Status711 - CANCELLED - SECTION 7
Status DateFriday, November 13, 2015
Registration Number4103919
Registration DateTuesday, February 28, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, November 13, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Friday, November 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 12, 2021INTERNATIONAL REGISTRATION RENEWED
Friday, February 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 21, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, July 14, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, July 14, 2016INVALIDATION PROCESSED
Wednesday, July 13, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 13, 2015CANCELLED SECTION 7-TOTAL
Friday, November 13, 2015CANCELLATION TERMINATED NO. 999999
Thursday, November 5, 2015CANCELLATION DENIED NO. 999999
Thursday, March 26, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, April 16, 2014CANCELLATION INSTITUTED NO. 999999
Monday, October 15, 2012NOTIFICATION PROCESSED BY IB
Saturday, October 13, 2012NOTIFICATION PROCESSED BY IB
Monday, August 13, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 13, 2012FINAL DISPOSITION PROCESSED
Thursday, March 29, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 28, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 7, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 23, 2011NOTICE OF PUBLICATION
Monday, November 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2011ASSIGNED TO EXAMINER
Friday, October 21, 2011APPLICATION FILING RECEIPT MAILED
Monday, October 17, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 14, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

remsima autoimmune diseases disorders treatment preparations pharmaceutical